Suckii, I think you're hugely over-reacting & over-chucking a huge narni over a miss of a $1 million when the BIG PICTURE is I believe still intact. Europe is what it is cause it obviously costs resources to address it. Better to focus on the US, get that right and then revisit Europe when we have the resources. WP may have had a big budget to play with at Merck but he's living on $2 minute noodles at AHZ. A limited sales team, with limited footprint, that can only do so much (even with the best killer product in town). Our lack of capital is holding us back.
Ann: Admedus announces facility agreement with PFG, page-174
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.56 |
Change
-0.740(5.56%) |
Mkt cap ! $265.4M | |||
| Open | High | Low | Value | Volume |
| $13.06 | $13.30 | $12.55 | $359.0K | 27.63K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 399 | $12.56 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.78 | 500 | 1 |
View Market Depth
| Last trade - 16.10pm 03/09/2024 (20 minute delay) ? |
| AVR (ASX) Chart |